U.S., Nov. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07239102) titled 'Firmonertinib in the Treatment of EGFR(+) NSCLC Patients With Central Nervous System Metastasis' on Nov. 16.
Brief Summary: This is a clinical retrospective study that will collect and analyze clinical data from all patients treated with fumeitinib mesylate in the Oncology Department of Tiantan Hospital between January 1, 2020 and May 31, 2025. The data collection will include general demographic characteristics (gender, age, family history, smoking history, etc.), clinicopathological features, NGS test reports, fumeitinib initiation time and dosage, concomitant medications, local treatments (surgery, radiotherapy, etc.), and baseli...